Inducible Expression of a MAP Kinase Phosphatase-3-GFP Chimera Specifically Blunts Fibroblast Growth and Ras-Dependent Tumor Formation in Nude Mice

Journal of Cellular Physiology

Volumn 199, Issue 3, 2004, Pages 441-450

  Marchetti, S ^a   Gimond, C ^a   Roux, D ^a   Gothie E ^a   Pouyssegur J ^a   Pagès, Gilles ^a,b  

^a Inst Sign Devmtl Biol/Cancer R   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHIMERIC PROTEIN; CYCLIN D1; DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 3; PHOSPHATASE; PROTEIN; RAS PROTEIN; TETRACYCLINE; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME STABILITY; ENZYME SUBSTRATE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C FOS; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR GROWTH;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CHIMERA; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RAS PROTEINS; TETRACYCLINE; TRANSFECTION;

ANIMALIA; MUS MUSCULUS;

EID: 2342522780     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10465     Document Type: Article

References (55)

1. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589-23597.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995a. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
3. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P. 1995b. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol 5:283-295.
4. Auerbach R, Morrissey LW, Sidki YA. 1978. Regional differences in the incidence and growth of mouse tumors following intradermal or sub-cutaneous inoculation. Cancer Res 38:1739-1744.
5. Babu GJ, Lalli MJ, Sussman MA, Sadoshima J, Periasamy M. 2000. Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J Mol Cell Cardiol 32:1447-1457.
6. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouysségur J. 1995. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10:1895-1904.
7. Brondello JM, Brunet A, Pouysségur J, McKenzie FR. 1997. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J Biol Chem 272:1368-1376.
8. Brunet A, Pouysségur J. 1997. Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem 32:1-16.
9. Brunet A, Pagès G, Pouysségur J. 1994. Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). FEBS Lett 346:299-303.
10. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouysségur J. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. Embo J 18:664-674.
11. Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U, Arkinstall S. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280:1262-1265.
12. Camps M, Nichols A, Arkinstall S. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. Faseb J 14:6-16.
13. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936-942.
14. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K. 1996. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271:6497-6501.
15. Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D. 1996. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol 16:5674-5682.
16. Dowd S, Sneddon AA, Keyse SM. 1998. Isolation of the human genes encoding the pystl and Pyst2 phosphatases: characterisation of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J Cell Sci 111:3389-3399.
17. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
18. Franklin CC, Kraft AS. 1997. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272:16917-16923.
19. Gille H, Sharrocks AD, Shaw PE. 1992. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
20. Gonzalez FA, Seth A, Raden DL, Bowman DS, Fay FS, Davis RJ. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 122:1089-1101.
21. Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM. 1996. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. Embo J 15:3621-3632.
22. Guan KL. 1994. The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 6:581-589.
23. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J. 1998. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 273:31327-31336.
24. Janknecht R, Ernst WH, Pingoud V, Nordheim A. 1993. Activation of ternary complex factor Elk-1 by MAP kinases. Embo J 12:5097-5104.
25. Kampfer S, Windegger M, Hochholdinger F, Schwaiger W, Pestell RG, Baier G, Grunicke HH, Uberall F. 2001. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J Biol Chem 276:42834-42842.
26. Keyse SM. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12:186-192.
27. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. 1997. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492.
28. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouysségur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20608-20616.
29. Lenormand P, Sardet C, Pagès G, L'Allemain G, Brunet A, Pouysségur J. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J Cell Biol 122:1079-1088.
30. Lenormand P, McMahon M, Pouysségur J. 1996. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J Biol Chem 271:15762-15768.
31. Lewis TS, Shapiro PS, Ahn NG. 1998. Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139.
32. Li X, Zhao X, Fang Y, Jiang X, Duong T, Fan C, Huang CC, Kain SR. 1998. Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 273:34970-34975.
33. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
34. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. 1982. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903.
35. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pagès G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Ehrengruber MU, Cestari V, Lipp HP, Chapman PF, Pouysségur J, Brambilla R. 2002. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34:807-820.
36. Milanini J, Vinals F, Pouysségur J, Pagès G. 1998. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
37. Milanini-Mongiat J, Pouysségur J, Pagès G. 2002. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639.
38. Muda M, Boschert U, Dickinson R, Martinou JC, Martinou I, Camps M, Schlegel W, Arkinstall S. 1996a. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 271:4319-43126.
39. Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S. 1996b. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271:27205-27208.
40. Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. 1991. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J Biol Chem 266:15266-15276.
41. Oh-hora M, Ogata M, Mori Y, Adachi M, Imai K, Kosugi A, Hamaoka T. 1999. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase. J Immunol 163:1282-1288.
42. Pagès G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouysségur J. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323.
43. Pagès G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouysségur J. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377.
44. Pouysségur J, Lenormand P. 2003. Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Eur J Biochem 270(16):3291-3299.
45. Richard DE, Berra E, Gothie E, Roux D, Pouysségur J. 1999a. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637.
46. Richard DE, Berra E, Gothie E, Roux D, Pouysségur J. 1999b. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637.
47. Rossomando AJ, Dent P, Sturgill TW, Marshak DR. 1994. Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol Cell Biol 14:1594-1602.
48. Saba-El-Lell MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, Meloche S. 2003. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4(10):964-968. Epub 2003 Sep 19.
49. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR, Saltiel AR. 1999. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5:810-816.
50. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ. 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem 267:24796-24804.
51. Seuwen K, Lagarde A, Pouysségur J. 1988. Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide-specific phospholipase C. Embo J 7:161-168.
52. Spandidos DA, Wilkie NM. 1984. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310(5977):469-475.
53. Tedford K, Kim S, Sa D, Stevens K, Tyers M. 1997. Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substrates. Curr Biol 7:228-238.
54. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288:351-355.
55. Volmat V, Camps M, Arkinstall S, Pouysségur J, Lenormand P. 2001. The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. J Cell Sci 114:3433-3443.